In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
10/- each at a premium of Rs.90 per share.In 1994-95, the company acquired the use of Brands, Trade Marks & Logos of the edible oil business from ITC Ltd in March, 1995 for a consideration of Rs.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果